Guangdong Chengwen Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Guangdong Chengwen Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include CYBERWHIP. The owner is based in Chancheng, Foshan.

Fenjiang South Road, Shiwan Town Street,

No. 2311-1, Building 1, No. 18

Chancheng, Foshan 528010 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CYBERWHIP
CYBERWHIP
Registered 2024

Trademark Classifications

Guangdong Chengwen Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does Guangdong Chengwen Technology Co., Ltd. have?

Guangdong Chengwen Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Guangdong Chengwen Technology Co., Ltd. file in?

Guangdong Chengwen Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 1 (Chemicals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are Guangdong Chengwen Technology Co., Ltd.'s most well-known trademarks?

Guangdong Chengwen Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as CYBERWHIP. These are among 1 currently registered trademark in the portfolio.

What is Guangdong Chengwen Technology Co., Ltd.'s trademark registration success rate?

Guangdong Chengwen Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.